UTRS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
UTRS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Minerva Surgical's annualized Net Income for the quarter that ended in Sep. 2023 was $-28.72 Mil. Minerva Surgical's average total tangible assets for the quarter that ended in Sep. 2023 was $53.26 Mil. Therefore, Minerva Surgical's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2023 was -53.94%.
The historical rank and industry rank for Minerva Surgical's Return-on-Tangible-Asset or its related term are showing as below:
During the past 4 years, Minerva Surgical's highest Return-on-Tangible-Asset was -33.27%. The lowest was -111.49%. And the median was -47.01%.
The historical data trend for Minerva Surgical's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minerva Surgical Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
Return-on-Tangible-Asset | -111.49 | -38.21 | -33.27 | -55.81 |
Minerva Surgical Quarterly Data | |||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Return-on-Tangible-Asset | Get a 7-Day Free Trial | -76.83 | -51.48 | -88.48 | -59.62 | -53.94 |
For the Medical Devices subindustry, Minerva Surgical's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Minerva Surgical's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Minerva Surgical's Return-on-Tangible-Asset falls into.
Minerva Surgical's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2022 is calculated as:
Return-on-Tangible-Asset | = | Net Income | / | ( (Total Tangible Assets | + | Total Tangible Assets) | / count ) |
(A: Dec. 2022 ) | (A: Dec. 2021 ) | (A: Dec. 2022 ) | |||||
= | Net Income | / | ( (Total Assets - Intangible Assets | + | Total Assets - Intangible Assets) | / count ) | |
(A: Dec. 2022 ) | (A: Dec. 2021 ) | (A: Dec. 2022 ) | |||||
= | -34.112 | / | ( (80.122 | + | 42.122) | / 2 ) | |
= | -34.112 | / | 61.122 | ||||
= | -55.81 % |
Minerva Surgical's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2023 is calculated as:
Return-on-Tangible-Asset | = | Net Income | / | ( (Total Tangible Assets | + | Total Tangible Assets) | / count ) |
(Q: Sep. 2023 ) | (Q: Jun. 2023 ) | (Q: Sep. 2023 ) | |||||
= | Net Income | / | ( (Total Assets - Intangible Assets | + | Total Assets - Intangible Assets) | / count ) | |
(Q: Sep. 2023 ) | (Q: Jun. 2023 ) | (Q: Sep. 2023 ) | |||||
= | -28.724 | / | ( (56.054 | + | 50.459) | / 2 ) | |
= | -28.724 | / | 53.2565 | ||||
= | -53.94 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2023) net income data.
Minerva Surgical (OTCPK:UTRS) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Thank you for viewing the detailed overview of Minerva Surgical's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Cohen | director | C/O ACCELMED, 848 BRICKELL AVE, #901, MIAMI FL 33131 |
Accelmed Partners Ii L.p. | 10 percent owner | 2875 NE 191ST, SUITE 500, AVENTURA FL 33180 |
New Enterprise Associates 13 Lp | 10 percent owner | 1119 ST PAUL STREET, BALTIMORE MD 21202 |
Uri Geiger | director, 10 percent owner | 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815 |
Todd Usen | director, officer: Chief Executive Officer | C/O MINERVA SURGICAL, INC., 4255 BURTON DRIVE, SANTA CLARA CA 95054 |
Derrick Sung | director | C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103 |
David M Clapper | director, officer: President and CEO | 3003 TASMAN DRIVE, SANTA CLARA CA 95054 |
Novo Holdings A/s | 10 percent owner | TUBORG HAVNEVEJ 19, HELLERUP G7 2900 |
Jaffe Ross A Md | director | ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104 |
Evgueni V. Skalnyi | officer: VP Medical Affairs | C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054 |
Dominique J. Filloux | officer: COO | C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054 |
Joel R Jung | officer: CFO | 1401 HARBOR BAY PARKWAY, ALAMEDA CA 94502 |
Niquette L. Hunt | director | SOLITON, INC., 5304 ASHBROOK DRIVE, HOUSTON TX 77081 |
Jill Anderson | director | 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095 |
Nea Partners 13, Limited Partnership | 10 percent owner | 1119 ST. PAUL STREET, BALTIMORE MD 21202 |
From GuruFocus
By GuruFocusNews insider • 02-11-2022
By GuruFocusNews GuruFocusNews • 06-29-2022
By Ds*** Ds*** • 08-29-2022
By GuruFocusNews GuruFocusNews • 05-20-2022
By GuruFocus Research GuruFocus Editor • 05-11-2022
By PurpleRose PurpleRose • 08-03-2022
By Value_Insider Value_Insider • 10-26-2022
By Stock market mentor Stock market mentor • 01-03-2023
By sperokesalga sperokesalga • 02-09-2023
By GuruFocusNews GuruFocusNews • 06-19-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.